|
|
|
Insider
Information: |
Pauwels Eric |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
97,694 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,601,856 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
97,694 |
|
|
Total
Value |
$2,601,856 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
10
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
10
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-10.0
|
Percentage
Gain/Loss : |
0.0%
|
-699.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Accuray Inc |
ARAY |
SVP Chief Marketing Of... |
2011-02-28 |
30,000 |
2011-02-28 |
0 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
President, NPS Pharma ... |
2015-02-21 |
0 |
2011-09-26 |
0 |
Premium* |
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-04-17 |
67,694 |
2020-04-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PTCT |
PTC Therapeutics, Inc. |
Chief Business OfficerOfficer |
|
2020-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,841 |
|
- |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2022-01-25 |
4 |
S |
$39.31 |
$14,114 |
D/D |
(359) |
50,961 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-01-24 |
4 |
S |
$47.45 |
$17,035 |
D/D |
(359) |
65,912 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2021-02-01 |
4 |
S |
$56.96 |
$20,618 |
D/D |
(362) |
36,487 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2024-01-30 |
4 |
S |
$27.25 |
$9,974 |
D/D |
(366) |
44,181 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2022-02-01 |
4 |
S |
$40.00 |
$14,681 |
D/D |
(367) |
50,594 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$17,111 |
D/D |
(375) |
65,537 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2021-01-25 |
4 |
S |
$62.05 |
$26,745 |
D/D |
(431) |
36,849 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$25,329 |
D/D |
(571) |
66,271 |
0 |
% |
|
NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
|
2014-08-01 |
4 |
D |
$27.86 |
$17,273 |
D/D |
(620) |
29,951 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-01-10 |
4 |
S |
$42.93 |
$28,465 |
D/D |
(663) |
66,842 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-04-18 |
4 |
S |
$52.04 |
$38,096 |
D/D |
(732) |
64,805 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2021-04-19 |
4 |
S |
$48.17 |
$37,860 |
D/D |
(786) |
35,701 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
|
2024-04-17 |
4 |
S |
$25.14 |
$19,781 |
D/D |
(787) |
67,694 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-05-18 |
4 |
AS |
$58.71 |
$46,267 |
D/D |
(788) |
55,969 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2022-01-04 |
4 |
S |
$41.16 |
$33,177 |
D/D |
(806) |
35,386 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2022-04-19 |
4 |
S |
$42.52 |
$34,947 |
D/D |
(822) |
49,772 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2023-01-09 |
4 |
S |
$41.66 |
$35,741 |
D/D |
(858) |
67,505 |
0 |
% |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2022-01-07 |
4 |
S |
$38.53 |
$33,363 |
D/D |
(866) |
34,520 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
|
2015-02-12 |
4 |
D |
$45.85 |
$43,878 |
D/D |
(957) |
24,934 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
|
2021-01-05 |
4 |
S |
$62.37 |
$66,549 |
D/D |
(1,067) |
27,080 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
|
2024-01-08 |
4 |
S |
$28.64 |
$44,937 |
D/D |
(1,569) |
46,612 |
0 |
% |
|
NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
|
2015-02-07 |
4 |
D |
$45.85 |
$76,203 |
D/D |
(1,662) |
23,104 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
|
2014-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
30,571 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
|
2014-02-07 |
4 |
D |
$35.13 |
$61,794 |
D/D |
(1,759) |
23,632 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|